Money, Money, Money! Raising Capital in the Post-GFC Market

Howard Moore is one of a handful of New Zealanders who have achieved success as a biotechnology entrepreneur.

He is also an experienced dairy industry executive with 25 years in the business. He entered the venture capital industry when he joined BioPacificVentures in March 2004 as executive director.

Prior to joining BioPacificVentures, Howard was executive vice president of Tercica Inc., a U.S.-based corporation he co-founded in Auckland before moving the business to San Francisco.  In March 2004, Tercica listed on the NASDAQ, only the second New Zealand-founded company to achieve a listing on the world's leading technology stock market.  Tercica's drug, Increlex (IGF-1) was approved on Aug 30, 2005 by the FDA for marketing.